Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Buzz on the Bullboards: Tracking Bombardier’s path, Tilray’s growth

This year began on a confusing path for investors as sectors struggle under greater inflation costs and hopes of an imminent interest rate cut fade. A few weeks later in 2024, we are starting to see a clearer picture of where many companies are headed this year. M...
Jonathon Brown | January 18, 2024 |

“Empowering” a New Revolution in Mind, Body and Health Care

When Stockhouse first met up with Empower Clinics Inc . ( CSE.CBDT , OTCQB: EPWCF , Forum ) back in February 2020 , the company was pioneering new technologies in the still-emerging medical cannabis and CBD markets. Fast-forward to today and Empower Clinics has pi...
Dave Jackson | December 15, 2021 |

Leap Therapeutics Lunges Forward on $132M Licensing Deal and $27M Equity Raise

Shares of Leap Therapeutics jumped 60% after the company reported that it signed an exclusive option and license agreement for its immuno-oncology drug DKN-01 with BeiGene in the Asia Pacific region excluding Japan. The firm also secured an additional $27 million in equity fin...
Streetwise Reports | January 6, 2020 |

Will People Accept Rampant Inflation? Hell, No!

The Weekly Missive, which usually arrives over the weekend (sometimes on Friday, sometimes on Sunday) was delayed this weekend for one reason: I had to change it. I started out last week with an idea that was leaning in the direction of full-on capitulation in the sen...
Streetwise Reports | June 24, 2020 |

PlantX Life: Must-see Investor Update with CEO Julia Frank

(Click image to play video) They truly have become “the digital face of the plant-based community” and they’re called Plant-X Life Inc. (VEGA) ( CSE.VEGA , Forum ) – a one-stop-shop and distribution company with a fast-gr...
Dave Jackson | February 22, 2021 |

Why XOM is close to an ideal option trading candidate

XOM has a hugely active options series, trades in both monthly and weekly expiration series and has bid / ask spreads that are just a few pennies wide. One of the most interesting aspects of options is the myriad opportunities presented for high probability trades for thos...
J.W. Jones | February 6, 2013 |

3D printing is a manufacturing game-changer

Calling all carnivores: ever thought about getting a meat printer? Of hand-crafting delectable beef steaks at home from plant proteins, that have the same texture, appearance and flavor as real meat, only without the distasteful killing part? 3D-printed steaks and chicken ...
Richard (Rick) Mills | November 15, 2019 |

Jim Rogers appointed director of Canadian gold junior

On April 17, 2012, a press release was issued by advanced junior gold exploration company, Spanish Mountain Gold ( TSX: V.SPA , Stock Forum ). It indicated the appointment of a new director to the company, namely, famed commodities investor, Jim Rogers. Up until that date,...
Tekoa Da Silva | October 28, 2012 |

An Emerging Medical Market Play with Great Opportunity

(Image via Bioasis Technologies Inc.) Biopharmaceutical Company Bioasis Technologies Inc. ( TSX-V: BTI , OTCQB: BIOAF , Forum ) is developing its proprietary xB 3TM platform technology to deliver therapeutics across the blood brain barrier (BBB) and int...
Stockhouse Editorial | July 28, 2020 |

Buzz on the Bullboards: Are We Headed for a Major Market Correction?

(Image via Datametrex AI Limited.) Datametrex AI Ltd. ( TSX-V: DM , Forum ) announced this week that achieved the highest net income and revenue in its history. A technology-focused company with exposure to Artificial Intelligence and Machine Learning, Datametr...
Stockhouse Editorial | August 18, 2021 |
1 2 3 4 5 6 7 8 9 10 ...